Alector Inc (ALEC)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart
Ticker: ALEC Exchange: NSM


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Total value Details
2024-03-05 2024-03-04 S Sale

Kenkare-Mitra Sara

President and Head of R&D

Officer
10,169 -3.1%
6.92
70,387 USD 		10,169 -3.1% 6.92 70,387 USD
2024-03-05 2024-03-04 S Sale

GRASSO MARC

Chief Financial Officer

Officer
5,716 -3.8%
6.92
39,562 USD 		5,716 -3.8% 6.92 39,562 USD
2024-03-05 2024-03-04 S Sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
18,837 -0.9%
6.92
130,386 USD 		18,837 -0.9% 6.92 130,386 USD
2024-03-05 2024-03-04 S Sale

Romano Gary

Chief Medical Officer

Officer
6,001 -3.0%
6.92
41,554 USD 		6,001 -3.0% 6.92 41,554 USD
2023-12-06 2023-12-04 S Sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
23,831 -1.2%
5.56
132,500 USD 		23,831 -1.2% 5.56 132,500 USD
2023-12-06 2023-12-04 S Sale

GRASSO MARC

Chief Financial Officer

Officer
4,574 -2.9%
5.56
25,431 USD 		4,574 -2.9% 5.56 25,431 USD
2023-12-06 2023-12-04 S Sale

Kenkare-Mitra Sara

President and Head of R&D

Officer
12,519 -3.7%
5.56
69,606 USD 		12,519 -3.7% 5.56 69,606 USD
2023-12-06 2023-12-04 S Sale

Romano Gary

Chief Medical Officer

Officer
5,035 -2.4%
5.56
27,995 USD 		5,035 -2.4% 5.56 27,995 USD
2023-09-13 2023-09-11 S Sale

Polaris Venture Management Co. VI, L.L.C.

Major owner
500,000 -4.4%
6.00
3,000,000 USD 		500,000 -4.4% 6.00 3,000,000 USD
2023-09-13 2023-09-11 S Sale

MCGUIRE TERRANCE

Non-Executive Director Major owner
500,000 -4.4%
6.00
3,000,000 USD 		500,000 -4.4% 6.00 3,000,000 USD
2023-09-06 2023-09-05 S Sale

Romano Gary

Chief Medical Officer

Officer
2,771 -2.7%
5.19
14,393 USD 		2,771 -2.7% 5.19 14,393 USD
2023-09-06 2023-09-05 S Sale

Kenkare-Mitra Sara

President and Head of R&D

Officer
6,214 -3.4%
5.19
32,277 USD 		6,214 -3.4% 5.19 32,277 USD
2023-09-06 2023-09-05 S Sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
5,647 -0.3%
5.19
29,333 USD 		5,647 -0.3% 5.19 29,333 USD
2023-09-06 2023-09-05 S Sale

GRASSO MARC

Chief Financial Officer

Officer
1,114 -3.3%
5.19
5,786 USD 		1,114 -3.3% 5.19 5,786 USD
2023-06-05 2023-06-02 S Sale

GRASSO MARC

Chief Financial Officer

Officer
1,050 -3.1%
6.90
7,249 USD 		1,050 -3.1% 6.90 7,249 USD
2023-06-05 2023-06-02 S Sale

Romano Gary

Chief Medical Officer

Officer
2,617 -2.5%
6.90
18,067 USD 		2,617 -2.5% 6.90 18,067 USD
2023-06-05 2023-06-02 S Sale

Kenkare-Mitra Sara

President and Head of R&D

Officer
4,092 -2.2%
6.90
28,250 USD 		4,092 -2.2% 6.90 28,250 USD
2023-06-05 2023-06-02 S Sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
5,255 -0.3%
6.90
36,279 USD 		5,255 -0.3% 6.90 36,279 USD
2023-03-21 2023-03-17 S Sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
15,186 -0.9%
6.22
94,428 USD 		15,186 -0.9% 6.22 94,428 USD
2023-03-03 2023-03-02 S Sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
5,849 -0.4%
8.32
48,651 USD 		5,849 -0.4% 8.32 48,651 USD
2023-03-03 2023-03-02 S Sale

Romano Gary

Chief Medical Officer

Officer
3,238 -3.0%
8.32
26,933 USD 		3,238 -3.0% 8.32 26,933 USD
2023-03-03 2023-03-02 S Sale

GRASSO MARC

Chief Financial Officer

Officer
1,291 -3.6%
8.32
10,739 USD 		1,291 -3.6% 8.32 10,739 USD
2023-03-03 2023-03-02 S Sale

Kenkare-Mitra Sara

President and Head of R&D

Officer
10,124 -5.1%
8.32
84,216 USD 		10,124 -5.1% 8.32 84,216 USD
2023-03-03 2022-12-02 S Sale

Romano Gary

Chief Medical Officer

Officer
2,145 -1.9%
8.71
18,679 USD 		2,145 -1.9% 8.71 18,679 USD
2022-09-07 2022-09-02 S Sale

King Robert

Chief Development Officer

Officer
176 -0.0%
10.62
1,869 USD 		176 -0.0% 10.62 1,869 USD
2022-09-07 2022-09-02 S Sale

Romano Gary

Chief Medical Officer

Officer
2,177 -2.4%
10.62
23,120 USD 		2,177 -2.4% 10.62 23,120 USD
2022-06-06 2022-06-02 PS Planned sale

King Robert

Chief Development Officer

Officer
177 -0.0%
8.71
1,542 USD 		177 -0.0% 8.71 1,542 USD
2022-03-03 2022-03-01 S Sale

King Robert

Chief Development Officer

Officer
287 -0.1%
15.57
4,468 USD 		287 -0.1% 15.57 4,468 USD
2021-12-14 2021-12-13 PS Planned sale

SULIMAN SHEHNAAZ

President and COO

Officer
10,898 -9.6%
21.73
236,802 USD 		10,898 -9.6% 21.73 236,802 USD
2021-12-14 2021-12-13 PS Planned sale

SULIMAN SHEHNAAZ

President and COO

Officer
64,102 -36.1%
21.16
1,356,347 USD 		64,102 -36.1% 21.16 1,356,347 USD
2021-12-14 2021-12-10 PS Planned sale

SULIMAN SHEHNAAZ

President and COO

Officer
8,874 -8.0%
22.33
198,192 USD 		8,874 -8.0% 22.33 198,192 USD
2021-12-14 2021-12-10 PS Planned sale

SULIMAN SHEHNAAZ

President and COO

Officer
66,126 -37.2%
21.69
1,433,975 USD 		66,126 -37.2% 21.69 1,433,975 USD
2021-12-10 2021-12-09 PS Planned sale

SULIMAN SHEHNAAZ

President and COO

Officer
2,643 -2.5%
23.40
61,858 USD 		2,643 -2.5% 23.40 61,858 USD
2021-12-10 2021-12-09 PS Planned sale

SULIMAN SHEHNAAZ

President and COO

Officer
72,357 -40.7%
22.80
1,649,986 USD 		72,357 -40.7% 22.80 1,649,986 USD
2021-12-10 2021-12-08 PS Planned sale

SULIMAN SHEHNAAZ

President and COO

Officer
38,489 -27.3%
23.01
885,690 USD 		38,489 -27.3% 23.01 885,690 USD
2021-12-10 2021-12-08 PS Planned sale

SULIMAN SHEHNAAZ

President and COO

Officer
36,511 -20.6%
22.56
823,626 USD 		36,511 -20.6% 22.56 823,626 USD
2021-12-03 2021-12-01 PS Planned sale

King Robert

Chief Development Officer

Officer
250 -0.0%
20.09
5,023 USD 		250 -0.0% 20.09 5,023 USD
2021-11-12 2021-11-11 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
55,000 -2.7%
25.00
1,375,000 USD 		55,000 -2.7% 25.00 1,375,000 USD
2021-11-12 2021-11-10 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
55,000 -2.6%
25.00
1,375,000 USD 		55,000 -2.6% 25.00 1,375,000 USD
2021-11-10 2021-11-09 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
15,000 -2.2%
25.00
375,000 USD 		15,000 -2.2% 25.00 375,000 USD
2021-11-10 2021-11-09 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
15,000 -2.2%
25.00
375,000 USD 		15,000 -2.2% 25.00 375,000 USD
2021-11-10 2021-11-09 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
15,000 -2.2%
25.00
375,000 USD 		15,000 -2.2% 25.00 375,000 USD
2021-11-10 2021-11-09 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
55,000 -2.6%
25.00
1,375,000 USD 		55,000 -2.6% 25.00 1,375,000 USD
2021-11-10 2021-11-08 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
15,000 -2.2%
25.00
375,000 USD 		15,000 -2.2% 25.00 375,000 USD
2021-11-10 2021-11-08 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
15,000 -2.2%
25.00
375,000 USD 		15,000 -2.2% 25.00 375,000 USD
2021-11-10 2021-11-08 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
15,000 -2.2%
25.00
375,000 USD 		15,000 -2.2% 25.00 375,000 USD
2021-11-10 2021-11-08 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
55,000 -2.5%
25.00
1,375,000 USD 		55,000 -2.5% 25.00 1,375,000 USD
2021-11-08 2021-11-05 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
15,000 -2.2%
25.00
375,000 USD 		15,000 -2.2% 25.00 375,000 USD
2021-11-08 2021-11-05 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
15,000 -2.2%
25.00
375,000 USD 		15,000 -2.2% 25.00 375,000 USD
2021-11-08 2021-11-05 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
15,000 -2.2%
25.00
375,000 USD 		15,000 -2.2% 25.00 375,000 USD
2021-11-08 2021-11-05 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
55,000 -2.4%
25.00
1,375,000 USD 		55,000 -2.4% 25.00 1,375,000 USD
2021-11-08 2021-11-04 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
15,000 -2.1%
25.00
375,000 USD 		15,000 -2.1% 25.00 375,000 USD
2021-11-08 2021-11-04 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
15,000 -2.1%
25.00
375,000 USD 		15,000 -2.1% 25.00 375,000 USD
2021-11-08 2021-11-04 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
15,000 -2.1%
25.00
375,000 USD 		15,000 -2.1% 25.00 375,000 USD
2021-11-08 2021-11-04 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
55,000 -2.4%
25.00
1,375,000 USD 		55,000 -2.4% 25.00 1,375,000 USD
2021-07-08 2021-07-07 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
17,149 -6.8%
39.32
674,220 USD 		17,149 -6.8% 39.32 674,220 USD
2021-07-08 2021-07-07 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
7,700 -3.0%
38.14
293,686 USD 		7,700 -3.0% 38.14 293,686 USD
2021-07-08 2021-07-07 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
4,900 -1.9%
37.41
183,332 USD 		4,900 -1.9% 37.41 183,332 USD
2021-07-08 2021-07-06 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
1,100 -0.5%
40.01
44,016 USD 		1,100 -0.5% 40.01 44,016 USD
2021-07-08 2021-07-06 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
10,495 -4.3%
39.20
411,411 USD 		10,495 -4.3% 39.20 411,411 USD
2021-07-08 2021-07-06 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
3,581 -1.4%
38.55
138,059 USD 		3,581 -1.4% 38.55 138,059 USD
2021-07-08 2021-07-06 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
1,000 -0.4%
37.43
37,434 USD 		1,000 -0.4% 37.43 37,434 USD
2021-07-08 2021-07-06 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
3,600 -1.4%
35.95
129,433 USD 		3,600 -1.4% 35.95 129,433 USD
2021-07-08 2021-07-06 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
10,224 -3.9%
35.10
358,813 USD 		10,224 -3.9% 35.10 358,813 USD
2021-06-21 2021-06-16 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
4,600 -1.7%
22.18
102,049 USD 		4,600 -1.7% 22.18 102,049 USD
2021-06-21 2021-06-15 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
30,000 -9.9%
22.07
661,953 USD 		30,000 -9.9% 22.07 661,953 USD
2021-06-10 2021-06-08 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
800 -0.3%
20.83
16,661 USD 		800 -0.3% 20.83 16,661 USD
2021-06-10 2021-06-08 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
2,200 -0.8%
19.89
43,753 USD 		2,200 -0.8% 19.89 43,753 USD
2021-06-10 2021-06-08 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
16,175 -5.5%
19.00
307,331 USD 		16,175 -5.5% 19.00 307,331 USD
2021-05-25 2021-05-21 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
14,975 -5.2%
18.14
271,681 USD 		14,975 -5.2% 18.14 271,681 USD
2021-05-20 2021-05-18 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
4,200 -1.5%
18.04
75,786 USD 		4,200 -1.5% 18.04 75,786 USD
2021-04-08 2021-04-07 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
45 -0.0%
19.83
892 USD 		45 -0.0% 19.83 892 USD
2021-04-08 2021-04-07 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
22,255 -9.4%
19.19
427,158 USD 		22,255 -9.4% 19.19 427,158 USD
2021-03-24 2021-03-23 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
13,800 -6.1%
22.21
306,498 USD 		13,800 -6.1% 22.21 306,498 USD
2021-03-24 2021-03-22 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
5,510 -2.5%
23.55
129,774 USD 		5,510 -2.5% 23.55 129,774 USD